Madrigal ramps up preparations for commercial launch of resmetirom in NASH
Despite positive clinical trials and funding rounds, Madrigal is expected to require more funding for its launch.
Despite positive clinical trials and funding rounds, Madrigal is expected to require more funding for its launch.